MARKET WIREBenzinga • 1d ago
BTIG Suspends Buy Rating on ZoetisBTIG suspends Buy rating on Zoetis (NYSE:ZTS).
Why ZTS Stock advanced +1.29% Today — RQD Quant Desk Flash
$78.80 +1.29% NYSE • Public Delayed / 60s Snapshot
Zoetis Inc. (ZTS) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C+ • HOLD / WATCH
Cap $32.56B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C+
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw C · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+4.9% Base Target
WHALE OPTIONS TUG-OF-WAR:61% Call Buyers ($3.6M)
39% PutsMax Pain: $77.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ZTS Stock advanced +1.29% Today — RQD Quant Desk Flash
Zoetis Inc. (ZTS) advanced +1.29% to $78.80 as options desks priced 61% call premium vs. 39% put protection around the $77 max-pain magnet. Solid 72% profit margin (26% return on capital), mixed timing at 12x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 13% of its 52-week range ($68.77 – $144.83) with RSI-14 at 60.4 (BULLISH MOMENTUM).
- ▸Whale Options Positioning: $3.6M in bullish call flow vs. $2.3M in put flow (Put/Call 0.65x, implied earnings swing ±6.9%).
- ▸Fundamental Anchor: Roarable C+ (Hold) backed by 71.8% gross margin and $2.3B annual free cash flow.
Live ZTS Headlines & Catalysts
MARKET WIREYahoo • 2d ago
IDEXX Laboratories Reports Soon: How Has The Stock Reacted To Past Earnings?IDEXX Laboratories (NASDAQ:IDXX) is scheduled to report its earnings on Monday, November 2, 2026. The company has a market value of about $45.5 billion. Over the last twelve months it generated $4.6 billion in revenue an
RISK WATCHYahoo • 2d ago
Zoetis (ZTS) Ascends While Market Falls: Some Facts to NoteIn the most recent trading session, Zoetis (ZTS) closed at $78.8, indicating a +1.29% shift from the previous trading day.
MARKET WIREYahoo • 2d ago
Michael Burry Portfolio: Top 5 Stock PicksMichael Burry always gets attention with his stock picks and market calls. He became famous for betting against subprime mortgages before the 2008 crisis, and his fund Scion Capital reportedly returned over 480% from Nov
MARKET WIREYahoo • 2d ago
Zoetis (ZTS) vs. IDXX and ELAN: Is Valuation Compression Creating a Rare Opportunity in Animal Health?Is ZTS a good stock to buy? We came across a bullish thesis on Zoetis Inc. on D Invests’s Substack. Since the thesis was published on June 26th, ZTS shares have edged higher as livestock and international sales partly of
MARKET WIREBenzinga • 2d ago
Morgan Stanley Maintains Overweight on Zoetis, Lowers Price Target to $82Morgan Stanley analyst Erin Wright maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $85 to $82.
CATALYSTYahoo • 2d ago
Zoetis (ZTS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CATALYSTYahoo • 3d ago
Zoetis (ZTS) Wins FDA Approval For Convenia RTU, Is The Undervaluation Case Still Intact?Zoetis (ZTS) just received FDA approval for Convenia RTU for Dogs, a long acting injectable antibiotic for skin infections, raising fresh questions about how its expanding canine portfolio might influence investor expect
MARKET WIREYahoo • 3d ago
Zoetis (ZTS) Stock May Be Undervalued After FDA Approval NewsZoetis has seen its share price fall sharply in recent years, so the key issue now is whether the current valuation still lines up with what the business is earning. With earnings in focus and sentiment reset, the questi
CATALYSTYahoo • 3d ago
Zoetis (ZTS) Won FDA Approval For A New Single Dose Dog AntibioticZoetis (NYSE:ZTS) received FDA approval for Convenia RTU for Dogs, a single-dose antibiotic for canine skin infections. The new formulation is designed for a smaller injection volume and can be used across a wide range o
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ZTS Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
ZTS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -30.66%⚡ TESTING RESISTANCE
2026-10-30O $79.84H $80.61L $79.22C $79.72VOL 4.12M
RES: $82.82SUP: $67.95SMA50: $75.05SMA200: $93.53
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ZTS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
2.8%/yr Implied 5Y Growth
vs. +2.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ZTS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ZTS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ZTS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
ZTS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ZTS stock moving today?
Why ZTS Stock advanced +1.29% Today — RQD Quant Desk Flash. Solid 72% profit margin (26% return on capital), mixed timing at 12x P/E—hold if owned, no rush to chase.